Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Baggott

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Cancer Medicine|July 21, 2025
Factors Associated With Self-Report Symptom Screening Adherence in Pediatric Cancer PatientsL Lee Dupuis, Emily Vettese, Catherine Aftandilian, et al.
BMJ Open Respiratory Research|May 22, 2024
DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks-a prospective observational study using digital markers and artificial intelligence-study protocolAmy Hai Yan Chan, Braden Te Ao, Christina Baggott, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood|September 9, 2021
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemiaJenna Rossoff, Christina Baggott, Snehit Prabhu, et al.
JAMA|November 13, 2024
Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical TrialL Lee Dupuis, Emily Vettese, Allison C Grimes, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2026
Factors associated with unplanned healthcare encounters in pediatric cancer patientsMelissa P Beauchemin, L Lee Dupuis, Catherine Aftandilian, et al.
JCO Oncology Practice|August 14, 2025
Factors Associated With Symptom Burden Among Pediatric Patients With CancerAdam P Yan, L Lee Dupuis, Catherine Aftandilian, et al.
Blood Advances|November 18, 2021
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium ReportVanessa A Fabrizio, Christine L Phillips, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic LeukemiaLiora M Schultz, Anne Eaton, Christina Baggott, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Cancer Medicine|July 21, 2025
Factors Associated With Self-Report Symptom Screening Adherence in Pediatric Cancer PatientsL Lee Dupuis, Emily Vettese, Catherine Aftandilian, et al.
BMJ Open Respiratory Research|May 22, 2024
DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks-a prospective observational study using digital markers and artificial intelligence-study protocolAmy Hai Yan Chan, Braden Te Ao, Christina Baggott, et al.
Eclinicalmedicine|November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patternsValentin Barsan, Yimei Li, Snehit Prabhu, et al.
Blood|September 9, 2021
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemiaJenna Rossoff, Christina Baggott, Snehit Prabhu, et al.
JAMA|November 13, 2024
Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical TrialL Lee Dupuis, Emily Vettese, Allison C Grimes, et al.
Blood Advances|August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortiumHeather E Stefanski, Anne Eaton, Christina Baggott, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2026
Factors associated with unplanned healthcare encounters in pediatric cancer patientsMelissa P Beauchemin, L Lee Dupuis, Catherine Aftandilian, et al.
JCO Oncology Practice|August 14, 2025
Factors Associated With Symptom Burden Among Pediatric Patients With CancerAdam P Yan, L Lee Dupuis, Catherine Aftandilian, et al.
Blood Advances|November 18, 2021
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium ReportVanessa A Fabrizio, Christine L Phillips, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic LeukemiaLiora M Schultz, Anne Eaton, Christina Baggott, et al.
Pageof 10